These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 12815332

  • 21. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
    Takahashi F, Finch JL, Denda M, Dusso AS, Brown AJ, Slatopolsky E.
    Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408
    [Abstract] [Full Text] [Related]

  • 22. Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure.
    Denda M, Finch J, Slatopolsky E.
    Am J Kidney Dis; 1996 Oct; 28(4):596-602. PubMed ID: 8840952
    [Abstract] [Full Text] [Related]

  • 23. Parathyroid hormone metabolism and its potential as a uremic toxin.
    Slatopolsky E, Martin K, Hruska K.
    Am J Physiol; 1980 Jul; 239(1):F1-12. PubMed ID: 6994509
    [Abstract] [Full Text] [Related]

  • 24. Effects of new vitamin D analogues on parathyroid function in chronically uraemic rats with secondary hyperparathyroidism.
    Hruby M, Ureña P, Mannstadt M, Schmitt F, Lacour B, Drüeke TB.
    Nephrol Dial Transplant; 1996 Sep; 11(9):1781-6. PubMed ID: 8918622
    [Abstract] [Full Text] [Related]

  • 25. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites.
    Schömig M, Ritz E.
    Nephrol Dial Transplant; 2000 Sep; 15 Suppl 5():18-24. PubMed ID: 11073270
    [Abstract] [Full Text] [Related]

  • 26. Direct injection of calcitriol or its analog improves abnormal gene expression in the hyperplastic parathyroid gland in uremia.
    Shiizaki K, Fukagawa M, Yuan Q, Hatamura I, Nii-Kono T, Saji F, Shigematsu T, Akizawa T.
    Am J Nephrol; 2008 Sep; 28(1):59-66. PubMed ID: 17901691
    [Abstract] [Full Text] [Related]

  • 27. [Parathormone as a uremic toxin. Physiopathological bases and general therapeutic guidelines].
    Brancaccio D, Galmozzi C, Pizzocaro G.
    Minerva Med; 1985 Mar 10; 76(9-10):377-82. PubMed ID: 3982693
    [No Abstract] [Full Text] [Related]

  • 28. Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice.
    Arcidiacono MV, Yang J, Fernandez E, Dusso A.
    Nephrol Dial Transplant; 2015 Mar 10; 30(3):434-40. PubMed ID: 25324357
    [Abstract] [Full Text] [Related]

  • 29. Treatment of severe hypercalcemia due to refractory hyperparathyroidism in renal transplant patients with the calcimimetic agent cinacalcet.
    Apostolou T, Damianou L, Kotsiev V, Drakopoulos S, Hadjiconstantinou V.
    Clin Nephrol; 2006 May 10; 65(5):374-7. PubMed ID: 16724661
    [Abstract] [Full Text] [Related]

  • 30. Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
    Slatopolsky E, Finch JL, Brown AJ, Ritter CS, Mizobuchi M, Plum LA, Clagett-Dame M, Sicinski RR, DeLuca HF.
    J Bone Miner Res; 2007 May 10; 22(5):686-94. PubMed ID: 17444814
    [Abstract] [Full Text] [Related]

  • 31. Vitamin D receptors and parathyroid glands.
    Landry CS, Ruppe MD, Grubbs EG.
    Endocr Pract; 2011 May 10; 17 Suppl 1():63-8. PubMed ID: 21454240
    [Abstract] [Full Text] [Related]

  • 32. Severe chronic kidney disease environment reduced calcium-sensing receptor expression in parathyroid glands of adenine-induced rats even without high phosphorus diet.
    Uchiyama T, Ohkido I, Nakashima A, Saito Y, Okabe M, Yokoo T.
    BMC Nephrol; 2020 Jun 09; 21(1):219. PubMed ID: 32517664
    [Abstract] [Full Text] [Related]

  • 33. Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans.
    Cañadillas S, Canalejo A, Santamaría R, Rodríguez ME, Estepa JC, Martín-Malo A, Bravo J, Ramos B, Aguilera-Tejero E, Rodríguez M, Almadén Y.
    J Am Soc Nephrol; 2005 Jul 09; 16(7):2190-7. PubMed ID: 15888568
    [Abstract] [Full Text] [Related]

  • 34. Calcium and phosphorus metabolism in chronic uremia.
    Fiaschi E, Mioni G, Maschio G, D'Angelo A, Ossi E.
    Nephron; 1975 Jul 09; 14(2):163-80. PubMed ID: 1093055
    [Abstract] [Full Text] [Related]

  • 35. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU.
    J Ren Nutr; 2006 Jul 09; 16(3):253-8. PubMed ID: 16825031
    [Abstract] [Full Text] [Related]

  • 36. [Cell proliferation of parathyroid gland in patients with progressive secondary hyperparathyroidism: Vitamin D receptor, calcium sensing receptor, and cell cycle regulation factor].
    Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Hirakata H, Iida M.
    Clin Calcium; 2005 Sep 09; 15 Suppl 1():206-16. PubMed ID: 16279026
    [No Abstract] [Full Text] [Related]

  • 37. Parathyroid function in uremic children during periods of renal insufficiency, hemodialysis, and transplantation.
    Gruskin AB, Root AW, Duckett GE, Baluarte HJ.
    J Pediatr; 1976 Nov 09; 89(5):755-62. PubMed ID: 789840
    [Abstract] [Full Text] [Related]

  • 38. Parathyroid function in uremic children with and without osteodystrophy.
    Roof BS, Piel CF, Rames L, Potter D, Gordan GS.
    Pediatrics; 1974 Mar 09; 53(3):404-9. PubMed ID: 4815261
    [No Abstract] [Full Text] [Related]

  • 39. The role of the parathyroid glands in the uremic syndrome.
    Ritz E, Stefanski A, Rambausek M.
    Am J Kidney Dis; 1995 Nov 09; 26(5):808-13. PubMed ID: 7485137
    [Abstract] [Full Text] [Related]

  • 40. [Role of vitamin D in the pathogenesis of renal osteodystrophy].
    Nakanishi S, Fukagawa M.
    Clin Calcium; 2004 Sep 09; 14(9):15-20. PubMed ID: 15577104
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.